Prostate cancer is the most commonly diagnosed cancer in men, accounting for 30 percent of all cancers in men. This year, approximately 240,890 men in the United States will be diagnosed with prostate cancer and an estimated 33,720 will die from the disease. Prostate cancer is second only to lung cancer as a leading cause of cancer deaths in men. During the period of 2000 to 2006, the average annual incidence of prostate cancer among African American men was 60 percent higher than among Caucasian men. In 2007, the prostate cancer death rate among African American men was approximately three times as high as that of Caucasian men. Currently, there is no cure for locally advanced or metastatic prostate cancer.
PCRP Perspectives: Keep Informed on Breakthroughs in Prostate Cancer Research
Innovative Minds in Prostate Cancer Today
The IMPaCT 2011 Conference was held March 9-12, 2011 in Orlando, Florida. Click here for more information.
- PCRP IMPaCT Video, "Transforming Research from Discovery to Cure"
- IMPaCT Investigator Highlights
- IMPaCT Keynote Session
- IMPaCT Plenary Session: The Prostate Cancer Project
- IMPaCT Plenary Session: Therapeutics
- IMPaCT Plenary Session: New Horizons
- IMPaCT Plenary Session: The Process of Basic Research to Phase III Trials Videos
- IMPaCT Plenary Session: Game-Changing Research Videos
- IMPaCT Symposium Session: Mechanisms of Disease Progression
- IMPaCT 2007 Conference
Congressional Appropriations
- $1.13 billion in FY97-11
- $80 million in FY12
Funding Summary
- 2,334 Awards in FY97-10
- Previous Applications Recommended for Funding
- Prostate Cancer Consortium Awards
Integration Panels
